No change in prevalence of symptoms of COPD between 1996 and 2006 in Finnish adults – a report from the FinEsS Helsinki Study

References

• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3: 442. doi: http://dx.doi.org/10.1371/journal.pmed.0030442.
   Google Scholar
• Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 765–73.
   Web of Science ®Google Scholar
• Raherison C, Girodet P-O. Epidemiology of COPD. Eur Respir J. 2009; 18: 213–21.
   Google Scholar
• Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, etal. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010; 65: 14–20. [PubMed Abstract].
   Google Scholar
• Miravitlles M, Soriano JB, Garcia-Rio F, Munos L, Duran-Tauleria E, Sanchez G, etal. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009; 64: 863–8. [PubMed Abstract].
   Google Scholar
• Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Mölken MP, etal. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med. 2001; 164: 590–6. [PubMed Abstract].
   Google Scholar
• Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, etal. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003; 97: 115–22.
   PubMed Web of Science ®Google Scholar
• Løkke A, Lange P, Scharling H, Fabrizius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006; 61: 935–9.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med. 2007; 4: 112. doi: http://dx.doi.org/10.1371/journal.pmed.0040112.
   Google Scholar
• Fabricius P, Løkke A, Marott JL, Vestbo J, Lange P. Prevalence of COPD in Copenhagen. Respir Med. 2011; 105: 410–7. [PubMed Abstract].
   Google Scholar
• Najafzadeh M, Marra CA, Lynd LD, Sadatsafavi M, FitzGerald JM, McManus B, etal. Future impact of various interventions on the burden of COPD in Canada: a dynamic population model. PLoS One. 2012; 7: e46746. doi: http://dx.doi.org/10.1371/journal.pone.0046746.
   Google Scholar
• Vasankari TM, Impivaara O, Heliövaara M, Hestaro S, Liippo K, Puukka P, etal. No increase in the prevalence of COPD in two decades. Eur Respir J. 2010; 36: 766–73. [PubMed Abstract].
   Google Scholar
• Simpson CR, Hippisley-Cox J, Sheikh A. Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51804 patients. Br J Gen Pract. 2010; 60: 277–84. doi: http://dx.doi.org/10.3399/bjgp10X514729 [PubMed Abstract].
   Google Scholar
• Soriano JB, Ancochea J, Miravitlles M, Garcia-Rio F, Duran-Tauleria E, Munos L, etal. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. Eur Respir J. 2010; 36: 758–65. [PubMed Abstract].
   Google Scholar
• Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance – United States, 1999–2011. Chest. 2013; 144: 284–305. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Kim TB, Oh YM, Chang YS, Cho YS, Jang AS, Cho SH, etal. COREA and KOLD Study Group. The reality of an intermediate type between asthma and COPD in practice. Respir Care. 2012; 57: 1248–53. [PubMed Abstract].
   Google Scholar
• de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, etal. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013; 8: e62985. doi: http://dx.doi.org/10.1371/journal.pone.0062985 [PubMed CentralFull Text].
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2015. Available from: http://www.goldcopd.org/ [cited 9 November 2015].
   Google Scholar
• Schermer TR, Smeele IJ, Thoonen BP, Lucas AE, Grootens JG, van Boxem TJ, etal. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J. 2008; 32: 945–52. [PubMed Abstract].
   Google Scholar
• Bakke PS, Rönmark E, Eagan T, Pistelli F, Annesi-Maesano I, Maly M, etal. Recommendations for epidemiological studies on COPD. ERS Task Force Report. Eur Respir J. 2011; 38: 1261–77. [PubMed Abstract].
   Google Scholar
• Roberts SD, Farber MO, Knox KS, Phillips GS, Bhatt NY, Mastronarde JG, etal. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest. 2006; 130: 200–6. [PubMed Abstract].
   Google Scholar
• Hansen JE, Sun X-G, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest. 2007; 131: 349–55. [PubMed Abstract].
   Google Scholar
• Cerveri I, Corsico AG, Accordini S, Niniano R, Ansaldo E, Antó JM, etal. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax. 2008; 63: 1040–5. [PubMed Abstract].
   Google Scholar
• Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, etal. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63: 1046–51. [PubMed Abstract].
   Google Scholar
• Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest. 2011; 139: 52–9. [PubMed Abstract].
   Google Scholar
• Pallasaho P, Lundbäck B, Meren M, Kiviloog J, Loit H-M, Larsson K, etal. Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med. 2002; 96: 759–69. [PubMed Abstract].
   Google Scholar
• Bjerg A, Ekerljung L, Middelveld R, Dahlén SE, Forsberg B, Franklin K, etal. Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA2LEN surveys. PLoS One. 2011; 6: e16082. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Pallasaho P, Kainu A, Sovijärvi ARA, Lindqvist A, Piirilä P. Combined effect of smoking and occupational exposure to dusts, gases or fumes on the incidence of COPD. COPD. 2014; 11: 88–95. doi: http://dx.doi.org/10.3109/15412555.2013.830095 [PubMed Abstract].
   Google Scholar
• Lindberg A, Bjerg-Bäcklund A, Rönmark E, Larsson L-G, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2006; 100: 264–72. [PubMed Abstract].
   Google Scholar
• Kainu A, Rouhos A, Sovijärvi A, Lindqvist A, Sarna S, Lundbäck B. COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence. Scand J Public Health. 2013; 41: 570–8. [PubMed Abstract].
   Google Scholar
• Nacul L, Soljak M, Samarasundera E, Hopkinson NS, Lacerda E, Indulkar T, etal. COPD in England: a comparison of expected, model-based prevalence and observed prevalence from general practice data. J Public Health (Oxf). 2011; 33: 108–16.
   PubMed Web of Science ®Google Scholar
• Falzon C, Soljak M, Elkin SL, Blake ID, Hopkinson NS. Finding the missing millions – the impact of a locally enhanced service for COPD on current and projected rates of diagnosis: a population-based prevalence study using interrupted time series analysis. Prim Care Respir J. 2013; 22: 59–63. [PubMed Abstract].
   Google Scholar
• Kainu A, Pallasaho P, Piirilä P, Lindqvist A, Sovijärvi A, Pietinalho A. Increase in prevalence of physician-diagnosed asthma in Helsinki during the Finnish Asthma Programme: improved recognition of asthma in primary care? A cross-sectional cohort study. Prim Care Respir J. 2013; 22: 64–71. [PubMed Abstract].
   Google Scholar
• Medical Research Council's Committee on the Aetiology of Chronic Bronchitis. Standardized questionnaires on respiratory symptoms. Br Med J. 1960; 2: 1665.
   PubMedGoogle Scholar
• Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J. 1991; 4: 257–66.
   PubMed Web of Science ®Google Scholar
• Pallasaho P, Lundbäck B, Läspä SL, Kotaniemi J, Sovijärvi ARA, Laitinen LA. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki study. Respir Med. 1999; 93: 798–809. [PubMed Abstract].
   Google Scholar
• Dales RE, Mehdizadeh A, Aaron SD, Vandemheen KL, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J. 2006; 28: 319–22. [PubMed Abstract].
   Google Scholar
• Von Hertzen L, Reunanen A, Impivaara O, Mälkiä E, Aromaa A. Airway obstruction in relation to symptoms in chronic respiratory disease – a nationally representative population study. Respir Med. 2000; 94: 356–63. [PubMed Abstract].
   Google Scholar
• Lundbäck B, Stjernberg N, Nyström L, Lundbäck K, Lindström M, Rosenhall L. An interview study to estimate prevalence of asthma and chronic bronchitis. Eur J Epidemiol. 1993; 9: 123–33.
   PubMed Web of Science ®Google Scholar
• Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L. Cigarette smoking gives more respiratory symptoms among women than men. The Nord-Trøndelag Health Study (HUNT). J Epidemiol Community Health. 2000; 54: 917–22. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Sørheim I-C, Johannessen A, Gulsvik A, Bakke PS, Silverman ED, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men?. Thorax. 2010; 65: 480–5.
   PubMed Web of Science ®Google Scholar
• Juusela M, Pallasaho P, Rönmark E, Sarna S, Sovijärvi A, Lundbäck B. Dose-dependent association of smoking and bronchial hyperresponsiveness. Eur Respir J. 2013; 42: 1503–12. [PubMed Abstract].
   Google Scholar
• Kotaniemi J-T, Sovijärvi A, Lundbäck B. Chronic obstructive pulmonary disease in Finland: prevalence and risk factors. COPD. 2005; 3: 331–9.
   Google Scholar
• Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax. 2009; 64: 894–900. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Watson L, Schouten JP, Löfdahl C-G, Pride NB, Laitinen LA, Postma DS. Predictors of COPD symptoms: does the sex of the patient matter?. Eur Respir J. 2006; 28: 311–8. [PubMed Abstract].
   Google Scholar
• Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D, etal. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011; 37: 264–72. [PubMed Abstract].
   Google Scholar
• Schlecht NF, Schwartzman K, Bourbeau J. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2005; 2: 183–91. [PubMed Abstract].
   Google Scholar
• Barr RG, Herbstman J, Speizer FE, Camargo CAJr.. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol. 2002; 155: 965–71. [PubMed Abstract].
   Google Scholar
• Hanania NA, Mannino DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, etal. Predicting risk of airflow obstruction in primary care: validation of the lung function questionnaire (LFQ). Respir Med. 2010; 104: 1160–70. [PubMed Abstract].
   Google Scholar
• Mintz ML, Yawn BP, Mannino DM, Donohue JF, Hanania NA, Grellet CA, etal. Prevalence of airway obstruction assessed by Lung Function Questionnaire. Mayo Clin Proc. 2011; 86: 375–81. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Available from: www.savutonsuomi.fi/en.php [cited 20 March 2016]..
   Google Scholar
• Kinnula VL, Vasankari T, Kontula E, Sovijarvi A, Saynajakangas O, Pietinalho A. The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. Prim Care Respir J. 2011; 20: 178–83. [PubMed Abstract].
   Google Scholar
• Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, etal. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006; 61: 663–70. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011; 378: 991–6. [PubMed Abstract].
   Google Scholar